GCell: The Newest All-In-One Solution in Regenerative Medicine
Are you a physician currently utilizing adipose tissue but growing tired of the time-consuming, arduous procedure? Are you having problems finding reagents that allow you to isolate stem cells? If so, GCell might be the solution for you.
What is GCell?
GCell is a revolutionary new machine poised to become the future of adipose stem cell processing. Its compactness and short processing time make it a valuable implement in any regenerative medicine practitioner’s office. GCell employs a process of mechanical breakdown, which shortens the treatment duration and keeps it within legal minimal-manipulation regulations.
How Does GCell Work?
Through a system of extremely small blades and filters, GCell homogenizes a sample of fat taken from anywhere in the body, turning it into a slurry of growth factors, proteins, and other components. GCell then filters out the stromal vascular fraction cells and uses a process called photoactivation to increase their vitality. The end result is a final product that can be administered to patients within forty minutes from the sample’s harvesting. This is a significant improvement over the previous, multi-hour long treatments that physicians have grown accustomed to, and this shortened timespan is greatly appreciated by both doctors and patients.
Why GCell?
GCell offers a single-session treatment, meaning patients only need to visit their clinic once without requiring follow-up treatments. This machine combines the convenience of its small size and lightweight build with the ability to accelerate the stem cell harvesting process. Additionally, GCell is designed to be an entirely enclosed system, ensuring samples remain in a sterile environment, which preserves the viability of samples and ensures positive outcomes for patients.
GCell: The Newest All-In-One Solution in Regenerative Medicine
GCell combines a grinder, a filter, and a photoactivation device, offering a turnkey solution that can take a physician from harvesting a fat sample to administering an injectable regenerative medicine therapy in less than an hour. GCell is especially useful for clinics just beginning to implement regenerative medicine into their practice, with its all-inclusive approach to stem cell isolation setting it a cut above the rest.
GCell’s Single Session Treatment Protocol
Unlike many other cellular therapies on the market, GCell provides a single-session treatment, eliminating the need for patients to return after their original treatment day. Its portability, small stature, and ability to accelerate the stem cell harvesting process make it ideal for clinics new to regenerative medicine, taking much of the rigor out of adipose-derived stem cell harvesting.
- Published in Corporate News / Blog
New Studies Show Mesenchymal Stem Cells Promising in Treatment of COVID-19
As the world continues to deal with the coronavirus, treatment options seem to be on everyone’s mind. There have been several studies regarding the use of umbilical cord-derived stem cells (and Mesenchymal Stem Cells in general), and the results have been trending upwards. As the field of regenerative medicine continues to advance, researchers such as those in the University of Miami continue to spearhead new and innovative ways of using regenerative medicine to treat a variety of conditions. These treatments, as their safety and efficacy grows, become important for both physicians and everyday individuals to be aware of, especially as they grow in availability.
One particular study, the one mentioned earlier conducted by researchers from the University of Miami, shows extremely promising results in the use of MSCs for the treatment of COVID-19.
While researchers first and foremost endeavored to verify whether this treatment was simply safe, they also ran tests in order to determine how useful it would be. The study was conducted among a group of twenty-four people, which were assigned at random to either control or treatment groups.
The results from the study seem to confer with what other researchers have discovered– in that stem cell therapies are entirely safe. Those patients that were administered 200 million MSCs were not seen to develop any adverse effects within the body, and patient survival was over twice as high in those treated with stem cells vs. those left untreated. Additionally, it was discovered that those that received the administration of cells also largely recovered within the first thirty days after receiving treatment at a greater rate than the placebo group.
This study and others like it highlight what practitioners of regenerative medicine have known through their own work for decades now– that Mesenchymal Stem Cells have the ability to target inflammation, regulate immune system function, and stimulate the recovery of cells. Global Stem Cells Group has been operating for years in these same treatments, treating patients around the world.
Through years of experience, and collaboration with expert researchers, Global Stem Cells Group, in partnership with Cellgenic, has developed cellular lines that have been used by physicians around the world in treating many conditions. For those interested in distributing or receiving treatment with regenerative medicine, or for further information, you can contact us by emailing info@stemcellsgroup.com
[dzs_video source=” https://youtu.be/mjbFrl15jf4″ config=”skinauroradefault” autoplay=”off” cue=”off” loop=”off” type=”normal” responsive_ratio=”default”]
- Published in Press Releases
Global Stem Cells Group Announces Partnership with Bioscience Cell Factory
Just earlier this week, Global Stem Cells Group has signed a historic agreement with a company known as Bioscience Cell Factory– this Dubai-based healthcare company will allow GSCG to act as their representatives operating in both the Middle East and Latin America. Through the acquisition of proprietary branding rights Global Stem Cells Groups will become committed to promote the widespread use of cellular therapy treatments that utilize Mesenchymal Stem Cells (MSCs).
This partnership is groundbreaking in nature, and promises to lead to a wide proliferation of cellular therapies in both the Middle East and Latin America, two regions that are rapidly developing, with a constantly-advancing standard of medical care. Global Stem Cells Group will be clinically equipped with the highest standards and quality procedures as set forth by the Bioscience Cell Factory, resulting in nothing but the best treatment methods available for patients around the world.
“I’m extremely excited about this partnership,” Said Benito Novas, CEO of the Global Stem Cells Group, “Bioscience Cell Factory is one of the most professional and scientifically-focused teams that I’ve ever had the pleasure of working with– I am looking forward to the start of what will be an extremely beneficial professional relationship that will provide our global reach with the quality of Bioscience’s laboratory,”
Indeed, the two firms are also announcing plans to do research together into the nature of adult Mesenchymal Stem Cells, and the benefits that they hold for the medical field. Through the training of physicians and the handling of cell samples in their laboratory, there are high hopes for the advancement of the field of regenerative medicine research. As one of the representatives of the Bioscience Cell Factory abroad, Global Stem Cells Group will further its goal of being a global leader in the regenerative medicine field.
About Bioscience Cell Factory
Bioscience Clinic is a global healthcare company that is based in Dubai, committed to the running of a laboratory for the banking and use of all sorts of allogeneic and autologous cellular products. Through the proliferation of cellular therapies throughout the world, Bioscience Clinic hopes to advance treatment options for some debilitating diseases that current medical science has been largely unable to target the root causes of.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
- Published in Press Releases
Global Stem Cells Group Announces Training in Cochabamba, Bolivia at the End of November
The Global Stem Cells Group, a multi-disciplinary community of scientists and physicians that are collaborating to treat diseases and lessen human suffering through the advancement of the field of regenerative medicine has announced that the construction of their Stem Cell Center in Cochabamba, Bolivia, has concluded. What’s more, the organization has announced that, in celebration of the facility’s completion, the Center’s inaugural training course will take place at the end of November.
The new facility located in Bolivia is the 35th Stem Cell Center in the world, strengthening the Global Stem Cells Group’s presence worldwide as they seek to expand research for and the
practice of regenerative medicine across the globe. Representatives from the Group and local physicians in the area will both see the impact of this new clinic, which will offer a permanent space within the country where experts in the field can train Bolivian physicians in the latest stem cell research.
“I am very excited for the opportunity to train more Bolivian physicians. We’ve been laying the groundwork for this Stem Cell Center for a very long time, and it feels almost like a dream to have to ready to unveil to the world by the end of November,” Said Benito Novas, founder and CEO of the Global Stem Cells Group, “To be able to have a permanent location in Cochabamba, and to have spots quickly filling up for this training– I think it speaks volumes to the future of regenerative medicine being a bright one,”
This inaugural training is intended to not only teach physicians the value of incorporating regenerative medicine into their own clinics, but to ensure that there is a vast store of all the necessary equipment and supplies that are required for the wide array of cellular therapies that are available for patients around the world– including a highly interactive study session that goes over the extraction, isolation, and application of PRP, Adipose, ad Bone Marrow Stem Cells.
The Center will also provide access to several texts detailing procedure processes and treatment options that are available for reference after the training is completed.
If you are interested in learning more about the Global Stem Cell Group’s Onsite Regenerative Medicine Training, or to book your seat, you can visit us at our training website
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
- Published in Press Releases
Vitanovas To Open Franchise Clinics in Brussels, Belgium and Cancun, Mexico
Global Stem Cells Group (GSCG) subsidiary Vitanovas is a mobile IV infusion company with a direct-to-consumer model, and it has officially announced that it will be breaking ground in two new locations, which will be developed into franchised clinics in Brussels, Belgium and Cancun, Mexico.
Vitanovas’ franchising model allows for rapid growth and constant upscaling in terms of the businesses’ service range, a crucial part of growing as a business. As such, Vitanovas has become one of the most rapidly growing companies under the divisions of Global Stem Cells Group, and for good reason. The IV Therapy market is a burgeoning one that offers great opportunity for advancement, and with footholds in both the Old World and the New, Vitanovas is sure to make the most of it.
“We’re in a great position to begin spreading Vitanovas treatments in Belgium and Mexico– the demand for preventative health services is greater than ever, and by offering these with a customizable and direct-to-home model, we are confident in our ability to provide services throughout the duration of the pandemic, and after,” Said Benito Novas, Vitanovas founder and CEO. “With these two franchises, we will be able to bring IV Therapy to Mexico and Belgium, and to their respective people. It’s an opportunity that needs to be shared,
Vitanovas is a company that has grown because it brings nothing but benefits to both physicians and patients. For patients, they find a much more comfortable experience with the Vitanovas business model of travelling to their home, and because of that our treatments can also be extremely customizable. What’s more, the Vitanovas treatment plans have been designed to keep patients out of hospitals, emergency rooms, and doctor’s offices.
And physicians are also happy with the growth of the business, as it has larger profit margins, is able to overcome social distancing limitations, and allows them to conduct consultations from the comfort of their own home.
About Vitanovas
VitaNovas is a mobile IV infusion company that provides in-home treatments with the final goal of revitalizing the body, replenishing your capabilities, and helping you regenerate functions that may have been lost over the years. We use our years of experience in the field to boost your health and energy levels, and to give you back the motivation and drive you may have lost– Giving our patients a new lease on life is what we strive for every day.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
- Published in Press Releases
Global Stem Cells Group CEO Benito Novas Confirmed Speaker at 1st Ibero-American Fellowship Program in Regenerative and Functional Medicine
The First International Iber-American University Diploma has been announced to focus on laser therapy, hormone therapy, and wellness, and brings with it over a dozen seasoned instructors. The fellowship program, which spans over multiple weeks, covers a variety of topics with the focus of expanding the professional vision of medical professionals, and furthering knowledge of the applications of lasers in gynecology and cosmetic medicine. Additionally, it will update physicians on the newest techniques developed around the world to improve the quality of life of patients. A variety of protocols will be covered, including office, operating room, and hormone-based procedures.
The Fellowship Program has been certified by Atlantic International University, which is a private university based in Honolulu, Hawaii. Those physicians who complete the fellowship will be asked to demonstrate their knowledge through the use of clinical case studies involving real patients. Additionally, AIU offers students the opportunity to supplement this program with resources in various areas of knowledge, at no extra cost.
Benito Novas, CEO of Global Stem Cells Group, had this to say about the conference: “I am extremely proud and excited to be bringing this conference to physicians around the world. The program has been organized and directed by dear friends of mine, who have put in countless hours to ensure over a dozen physicians from a wide variety of specialties– really, nearly every field of medicine will be represented, and the course has been structured to ensure maximum retention for each and every student of ours,”
As a result, Global Stem Cells Group and the International Society for Stem Cells Application have both officially endorsed the course as a way for a physician to increase his knowledge in subjects ranging from cosmetic surgery, to marketing strategies, to hormone therapy, and everything in between. To learn more about the First International Ibero-American University Diploma, you may send an email to aiu-curso@amgerweb.com.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
- Published in Press Releases
ISSCA Announces Speaker’s List for 7th Annual Symposium
The International Society for Stem Cells Applications has officially announced and published its list of speakers for its 7th Annual Regenerative Medicine Symposium. The seventh event of its kind, it is another effort from the iSSCA to bring together a network of regenerative medicine practitioners from all over the world. At previous events, hundreds of physicians came to share in their knowledge regarding cellular therapies and the patients whose lives they can change, and the aim of this year is no different– of course, as a reunion of medical professionals, several steps will be taken to ensure proper social distancing measures, as well as frequent opportunities for sanitation.
As with previous editions of the event, the topics discussed and speakers involved have been updated and edited in an effort to reflect the changing of time and the rapid evolution of the field of regenerative medicine. That is why this symposium will focus on Cellular Therapies During and After the Pandemic. Coronavirus has changed life as we know it, but the scientific and medical communities have not stopped researching. In fact, cellular therapies have been an invaluable asset in managing the largest pandemic in modern history, due to their implications in treating respiratory failure and managing some of the complications induced by exposure to COVID-19. This has resulted in accelerated pathways for regulatory approval and increased funding for new regenerative medicine-based clinical trials, which will all be discussed in greater depth at the event.
But the Regenerative Medicine Symposium also provides a valuable networking opportunity for physicians in the Latin American community. “Here, people interested in cellular therapy can find everything they need to get on the right path to helping people with regenerative medicine,” Said Benito Novas, VP of Public Relations, ISSCA, “If you’ve done some research yourself, or really have no idea where to start– this would be the place. We’ve got vendors, instructors, and interview panels with several distinguished researchers,”
About ISSCA
The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine.
Their code of ethics emphasizes principles of morals and ethical conducts.
At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.
For more information, please visit us at www.issca.us or send an email to info@stemcellsgroup.com.
- Published in Press Releases
Global Stem Cells Group To Start Training Physicians In Lisbon, Portugal as Early as Sep. 2020
The Global Stem Cells Group has at last finalized discussions to open a The Stem Cell Center Network site in Lisbon, portugal. The Stem Cell Center operates an international network of regenerative medicine practitioners that is dedicated to sharing information with the end goal of bringing cutting-edge regenerative medicine-based treatments to patients suffering from debilitating disease.
The new Portuguese Stem Cell Center will be comprised of a highly-accredited, state of the art clinic/laboratory manned by physicians and scientists with combined decades of experience. It will be another strong foothold in Iberia for the global company, and carries with it full license to use the Group’s proprietary treatment methods and branding designs.
This will be the Global Stem Cell Group’s first permanent location in Portugal, rounding out the company’s presence in Western Europe and the Portuguese-speaking market with the new Lisbon-based partnership. The Stem Cell Center Network continues to roll out new membership opportunities, programs, and events, and our membership has grown steadily year after year– To date, we are present in twenty five countries and five continents.
And to commemorate this partnership the Stem Cell Network has plans to open the clinic in September of 2020, and begin training physicians shortly after. “We’ve wanted to expand into Portugal for a very long time,” Said Benito Novas, Founder and CEO, Global Stem Cells Group, “Now that the world is tentatively opening up, it seemed like a good time to resume teaching physicians– after all, with more people getting sick, it is important for their doctors to have all the tools at their fingertips to help,”
Barring any extenuating circumstances, the Stem Cell Center Network remains scheduled to open in the first week of September, with bookings already being accepted for the Network’s inaugural training at this clinic. With limited availability due to current social distancing efforts, spots are filling up quickly, and prospective applicants are encouraged to sign up soon for the hands-on training course.
To Sign Up Today, Visit us At: www.issca.us
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
- Published in Press Releases
Global Stem Cells Group CEO Benito Novas Confirmed Speaker at 1st Ibero-American Fellowship Program in Regenerative and Functional Medicin
The First International Iber-American University Diploma has been announced to focus on laser therapy, hormone therapy, and wellness, and brings with it over a dozen seasoned instructors. The fellowship program, which spans over multiple weeks, covers a variety of topics with the focus of expanding the professional vision of medical professionals, and furthering knowledge of the applications of lasers in gynecology and cosmetic medicine. Additionally, it will update physicians on the newest techniques developed around the world to improve the quality of life of patients. A variety of protocols will be covered, including office, operating room, and hormone-based procedures.
The Fellowship Program has been certified by Atlantic International University, which is a private university based in Honolulu, Hawaii. Those physicians who complete the fellowship will be asked to demonstrate their knowledge through the use of clinical case studies involving real patients. Additionally, AIU offers students the opportunity to supplement this program with resources in various areas of knowledge, at no extra cost.
Benito Novas, CEO of Global Stem Cells Group, had this to say about the conference: “I am extremely proud and excited to be bringing this conference to physicians around the world. The program has been organized and directed by dear friends of mine, who have put in countless hours to ensure over a dozen physicians from a wide variety of specialties– really, nearly every field of medicine will be represented, and the course has been structured to ensure maximum retention for each and every student of ours,”
As a result, Global Stem Cells Group and the International Society for Stem Cells Application have both officially endorsed the course as a way for a physician to increase his knowledge in subjects ranging from cosmetic surgery, to marketing strategies, to hormone therapy, and everything in between. To learn more about the First International Ibero-American University Diploma, you may send an email to aiu-curso@amgerweb.com.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
- Published in Press Releases
